MYCN Drives a Tumor Immunosuppressive Environment Which Impacts Survival in Neuroblastoma

A wide range of malignancies presents MYCN amplification (MNA) or dysregulation. MYCN is associated with poor prognosis and its over-expression leads to several dysregulations including metabolic reprogramming, mitochondria alteration, and cancer stem cell phenotype. Some hints suggest that MYCN ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Raieli, Salvatore, Di Renzo, Daniele, Lampis, Silvia, Amadesi, Camilla, Montemurro, Luca, Pession, Andrea, Hrelia, Patrizia, Fischer, Matthias, Tonelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951059/
https://www.ncbi.nlm.nih.gov/pubmed/33718189
http://dx.doi.org/10.3389/fonc.2021.625207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951059/
https://www.ncbi.nlm.nih.gov/pubmed/33718189
http://dx.doi.org/10.3389/fonc.2021.625207

Ejemplares similares